CCXI
Price:
$51.99
Market Cap:
$0
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of patients with severe hidradenitis suppurativa, as well as patients with complement 3 glomerulopathy, and lupus nephritis. In addition, it develops CCX559, an orally administered inhibitor for programmed death protein 1/programmed death-ligand 1 for ...[Read more]
Industry
Biotechnology
IPO Date
2012-02-08
Stock Exchange
NASDAQ
Ticker
CCXI
According to ChemoCentryx, Inc.’s latest financial reports and current stock price. The company's current ROE is -38.43%. This represents a change of 217.90% compared to the average of -12.09% of the last 4 quarters.
The mean historical ROE of ChemoCentryx, Inc. over the last ten years is -62.99%. The current -38.43% ROE has changed -39.00% with respect to the historical average. Over the past ten years (40 quarters), CCXI's ROE was at its highest in in the December 2017 quarter at 50.03%. The ROE was at its lowest in in the December 2018 quarter at -73.18%.
Average
-62.99%
Median
-44.16%
Minimum
-257.61%
Maximum
22.53%
Discovering the peaks and valleys of ChemoCentryx, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 495.05%
Maximum Annual ROE = 22.53%
Minimum Annual Increase = -1243.38%
Minimum Annual ROE = -257.61%
| Year | ROE | Change |
|---|---|---|
| 2021 | -45.11% | 214.22% |
| 2020 | -14.36% | -82.93% |
| 2019 | -84.07% | -67.36% |
| 2018 | -257.61% | -1243.38% |
| 2017 | 22.53% | -128.13% |
| 2016 | -80.10% | 22.78% |
| 2015 | -65.24% | 50.99% |
| 2014 | -43.21% | 62.36% |
| 2013 | -26.61% | -26.38% |
| 2012 | -36.15% | 495.05% |
The current ROE of ChemoCentryx, Inc. (CCXI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-47.85%
5-year avg
-75.72%
10-year avg
-62.99%
ChemoCentryx, Inc.’s ROE is greater than CymaBay Therapeutics, Inc. (-64.17%), less than RayzeBio, Inc. Common Stock (82.72%), greater than SpringWorks Therapeutics, Inc. (-51.10%), greater than Mirati Therapeutics, Inc. (-61.91%), less than Opthea Limited (520.65%), greater than Morphic Holding, Inc. (-29.08%), greater than MorphoSys AG (-183.80%), greater than Chinook Therapeutics, Inc. (-41.23%), greater than Longboard Pharmaceuticals, Inc. (-16.26%), greater than Alpine Immune Sciences, Inc. (-12.69%),
| Company | ROE | Market cap |
|---|---|---|
| -64.17% | $3.73B | |
| 82.72% | $3.75B | |
| -51.10% | $3.54B | |
| -61.91% | $4.12B | |
| 520.65% | $4.24B | |
| -29.08% | $2.86B | |
| -183.80% | $2.86B | |
| -41.23% | $2.71B | |
| -16.26% | $2.34B | |
| -12.69% | $4.46B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ChemoCentryx, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ChemoCentryx, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is ChemoCentryx, Inc.'s ROE?
How is the ROE calculated for ChemoCentryx, Inc. (CCXI)?
What is the highest ROE for ChemoCentryx, Inc. (CCXI)?
What is the 3-year average ROE for ChemoCentryx, Inc. (CCXI)?
What is the 5-year average ROE for ChemoCentryx, Inc. (CCXI)?
How does the current ROE for ChemoCentryx, Inc. (CCXI) compare to its historical average?